Article Text

Download PDFPDF

Evaluation of a clinical pharmacist consultation service for patients with infectious diseases in China: a systematic review and meta-analysis
  1. Jiaxing Zhang1,
  2. Xiaosi Li2,
  3. Juan Xie1,
  4. Wenyi Zheng3
  1. 1 Department of Pharmacy, Guizhou Provincial People's Hospital, Guiyang, China
  2. 2 Department of Pharmacy, Hospital of Chengdu Office of People’s Government of Tibetan Autonomous Region, Chengdu, China
  3. 3 Experimental Cancer Medicine, Clinical Research Center, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
  1. Correspondence to Dr Xiaosi Li, Department of Pharmacy, Hospital of Chengdu Office of People’s Government of Tibetan Autonomous Region, Chengdu 610000, China; lixiaosiyyy{at}


Background Since antibiotic resistance has become a global public health issue, a clinical pharmacist consultation service has been established in China.

Objectives To clarify the role of the clinical pharmacist consultation service in the management of infectious diseases (ID).

Methods Medline, Embase, Cochrane Library, Chinese National Knowledge Infrastructure, Chinese Biomedical Database, Vip Database and Wanfang Database were searched for studies meeting predefined inclusion criteria. The pooled acceptance rate of consultation (ARC) and effective rate of patients treated with the acceptance of pharmacists’ suggestions (ERA) were then calculated.

Results Fifty studies (involving 8616 patients and 8828 consultations) from 17 different provinces in China were included. The pooled ARC and ERA were 93.13% (95% CI 90.62% to 95.00%) and 93.60% (95% CI 91.99% to 95.24%), respectively. Adopting pharmacists’ suggestions can significantly improve the prognosis of patients with ID with a risk ratio of 2.08 (95% CI 1.41 to 3.06). Factors such as study time, characteristics of the research institution and patients have important influences on ARC.

Conclusion Prospective cohort studies with better methodology are needed, although a series of uncontrolled studies has shown that the service has excellent acceptance and improves the effectiveness of treatment for ID.

  • clinical pharmacy
  • consultation service
  • infectious diseases
  • systematic review
  • meta-analysis
  • case series

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, an indication of whether changes were made, and the use is non-commercial. See:

View Full Text

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.